Terms: = Ovarian cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1
105 results:
1. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
[TBL] [Abstract] [Full Text] [Related]
2. Dinuclear gold(I) complexes based on carbene and diphosphane ligands: bis[2-(dicyclohexylphosphano)ethyl]amine complex inhibits the proteasome activity, decreases stem cell markers and spheroid viability in lung cancer cells.
Casagrande N; Borghese C; Corona G; Aldinucci D; Altaf M; Sulaiman AAA; Isab AA; Ahmad S; Peedikakkal AMP
J Biol Inorg Chem; 2023 Dec; 28(8):751-766. PubMed ID: 37955736
[TBL] [Abstract] [Full Text] [Related]
3. Mechanisms of carboplatin- and paclitaxel-dependent induction of premature senescence and pro-cancerogenic conversion of normal peritoneal mesothelium and fibroblasts.
Rutecki S; Pakuła-Iwańska M; Leśniewska-Bocianowska A; Matuszewska J; Rychlewski D; Uruski P; Stryczyński Ł; Naumowicz E; Szubert S; Tykarski A; Mikuła-Pietrasik J; Książek K
J Pathol; 2024 Feb; 262(2):198-211. PubMed ID: 37941520
[TBL] [Abstract] [Full Text] [Related]
4.
Chen B; Jiang K; Wang H; Miao L; Lin X; Chen Q; Jing L; Lu X
Front Biosci (Landmark Ed); 2023 Sep; 28(9):220. PubMed ID: 37796700
[TBL] [Abstract] [Full Text] [Related]
5. Targeting Inhibition of Notch 1 Can Promote mTOR Signaling Pathway in Tumor-Related Macrophage to Regulate the Development of ovarian cancer.
Guo C; Mo J; Liu X; Chen Y; Liang L; Li H; Yang L
Altern Ther Health Med; 2023 Nov; 29(8):364-369. PubMed ID: 37632963
[TBL] [Abstract] [Full Text] [Related]
6. CD109 Promotes Drug Resistance in A2780 ovarian cancer Cells by Regulating the STAT3-notch1 Signaling Axis.
Kim JS; Shin MJ; Lee SY; Kim DK; Choi KU; Suh DS; Kim D; Kim JH
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373457
[TBL] [Abstract] [Full Text] [Related]
7. The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via notch1 pathway.
Yang L; Yang M; Cui C; Long X; Li Y; Dai W; Lang T; Zhou Q
Cell Signal; 2023 Jul; 107():110688. PubMed ID: 37105506
[TBL] [Abstract] [Full Text] [Related]
8. A
Jiang W; Ouyang X; Jiang C; Yin L; Yao Q; Pei X; Ji Z; Li M; Song S; Yang W; Huang S; Yang H; Shan B
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982170
[TBL] [Abstract] [Full Text] [Related]
9. Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development.
Chai H; Pan C; Zhang M; Huo H; Shan H; Wu J
BMC Cancer; 2023 Jan; 23(1):96. PubMed ID: 36707804
[TBL] [Abstract] [Full Text] [Related]
10. RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway.
Chen S; Cai K; Zheng D; Liu Y; Li L; He Z; Sun C; Yu C
Cell Death Dis; 2022 Nov; 13(11):945. PubMed ID: 36351890
[TBL] [Abstract] [Full Text] [Related]
11. Endothelial RBPJ Is Essential for the Education of Tumor-Associated Macrophages.
Alsina-Sanchis E; Mülfarth R; Moll I; Böhn S; Wiedmann L; Jordana-Urriza L; Ziegelbauer T; Zimmer E; Taylor J; De Angelis Rigotti F; Stögbauer A; Giaimo BD; Cerwenka A; Borggrefe T; Fischer A; Rodriguez-Vita J
Cancer Res; 2022 Dec; 82(23):4414-4428. PubMed ID: 36200806
[TBL] [Abstract] [Full Text] [Related]
12. WNT6 participates in the occurrence and development of ovarian cancer by upregulating/activating the typical Wnt pathway and notch1 signaling pathway.
Bao H; Wu W; Li Y; Zong Z; Chen S
Gene; 2022 Dec; 846():146871. PubMed ID: 36075327
[TBL] [Abstract] [Full Text] [Related]
13. Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous ovarian cancer.
Xu J; Fang Y; Chen K; Li S; Tang S; Ren Y; Cen Y; Fei W; Zhang B; Shen Y; Lu W
Clin Cancer Res; 2022 Aug; 28(16):3590-3602. PubMed ID: 35675036
[TBL] [Abstract] [Full Text] [Related]
14. Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047).
Sa JK; Kim J; Kang S; Kim SW; Song T; Shim SH; Choi MC; No JH; Song JY; Kim D; Kim YM; Kim JH; Lee JW
Int J Cancer; 2022 Oct; 151(7):1086-1097. PubMed ID: 35666535
[TBL] [Abstract] [Full Text] [Related]
15. Knockdown of growth factor receptor bound protein 7 suppresses angiogenesis by inhibiting the secretion of vascular endothelial growth factor A in ovarian cancer cells.
Xu Q; Liu Z; Zhu ZQ; Fan Y; Chen R; Xie XH; Cheng M
Bioengineered; 2021 Dec; 12(2):12179-12190. PubMed ID: 34783299
[TBL] [Abstract] [Full Text] [Related]
16. Overexpression of BMP9 promotes ovarian cancer progression via notch1 signaling.
Yang L; Bai Y; Zhang C; Du J; Cheng Y; Wang Q; Zhang B; Yang Y
Neoplasma; 2021 Nov; 68(6):1190-1200. PubMed ID: 34533030
[TBL] [Abstract] [Full Text] [Related]
17. Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via notch1/slug signaling.
Wang K; Liu S; Dou Z; Zhang S; Yang X
Cancer Sci; 2021 Oct; 112(10):4220-4233. PubMed ID: 34363722
[TBL] [Abstract] [Full Text] [Related]
18. Chemokine CCL20 promotes the paclitaxel resistance of CD44
Chen M; Su J; Feng C; Liu Y; Zhao L; Tian Y
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278466
[TBL] [Abstract] [Full Text] [Related]
19. Theasaponin E
Li B; Tong T; Ren N; Rankin GO; Rojanasakul Y; Tu Y; Chen YC
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802884
[TBL] [Abstract] [Full Text] [Related]
20. Features of the Copy Number Variation of Certain Genes in Tumor Cells in Patients with Serous ovarian Adenocarcinoma.
Kutilin DS; Tsandekova MR; Porkhanova NV
Bull Exp Biol Med; 2021 Jan; 170(3):332-339. PubMed ID: 33452985
[TBL] [Abstract] [Full Text] [Related]
[Next]
